Graphical summary: mutations emerging after in vitro priming phase were monitored in tumors grown in immunodeficient and immunocompetent syngeneic mice. Mutations retained in both in vivo models are listed as immune neutral, whereas mutations maintained in tumors grown in immunodeficient mice and negatively selected in immunocompetent mice are indicated as immunoedited.
